Hikma Pharma H1 Profit Down, Revenues Up; Lifts FY23 Forecast For Generics

(RTTNews) - Hikma Pharmaceuticals PLC (HIK, HIK.L) reported Thursday that its first-half profit attributable to shareholders fell 24 percent to $131 million from last year's $173 million. Basic earnings per share were 59.3 cents, down 22 percent from last year's 76.2 cents. https://www.nasdaq.com/articles/hikma-pharma-h1-profit-down-revenues-up-lifts-fy23-forecast-for-generics